QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
NASDAQ:LQDA

Liquidia (LQDA) Price Target & Analyst Ratings

$6.35
+0.04 (+0.63%)
(As of 01:57 PM ET)
Compare
Today's Range
$6.26
$6.37
50-Day Range
$6.27
$8.15
52-Week Range
$4.35
$9.95
Volume
101,109 shs
Average Volume
520,425 shs
Market Capitalization
$411.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.75

Liquidia Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$13.75
116.54% Upside
High Prediction$18.00
Average Prediction$13.75
Low Prediction$3.00
TypeCurrent
9/27/22 to 9/27/23
1 Month Ago
8/28/22 to 8/28/23
3 Months Ago
6/29/22 to 6/29/23
1 Year Ago
9/27/21 to 9/27/22
Consensus Rating
Hold
Hold
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$13.75$13.75$14.00$13.67
Predicted Upside116.54% Upside83.33% Upside147.95% Upside165.16% Upside
Get Liquidia Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.


LQDA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LQDA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Liquidia Stock vs. The Competition

TypeLiquidiaMedical CompaniesS&P 500
Consensus Rating Score
2.33
2.66
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside118.25% Upside1,359.74% Upside697.22% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/26/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$18.00+187.08%
8/14/2023Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUnderperform ➝ Underperform$3.00-57.87%
8/11/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$16.00+123.46%
7/6/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$20.00 ➝ $18.00+127.27%
(Data available from 9/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












LQDA Price Target - Frequently Asked Questions

What is Liquidia's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Liquidia stock is Hold based on the current 1 sell rating and 2 buy ratings for LQDA. The average twelve-month price prediction for Liquidia is $13.75 with a high price target of $18.00 and a low price target of $3.00. Learn more on LQDA's analyst rating history.

Do Wall Street analysts like Liquidia more than its competitors?

Analysts like Liquidia less than other Medical companies. The consensus rating for Liquidia is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how LQDA compares to other companies.

Does Liquidia's stock price have much upside?

According to analysts, Liquidia's stock has a predicted upside of 96.35% based on their 12-month price targets.

What analysts cover Liquidia?

Liquidia has been rated by BTIG Research, HC Wainwright, Needham & Company LLC, and Wedbush in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:LQDA) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -